Zuzana Biesova - Sensei Biotherapeut Inc

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

VISTA Checkpoint Inhibition by Ph-Selective Antibody SNS-101 with Optimized Safety and Pharmacokinetic Profiles Enhances PD-1 Response

Thomas Thisted,F. Donelson Smith,Arnab Mukherjee,Yuliya Kleschenko, Feng,Zhi-Gang Jiang, Timothy Eitas,Kanam Malhotra,Zuzana Biesova, Adejumoke Onumajuru,Faith Finley,Anokhi Cifuentes, Guolin Zhang,Gaelle H. Martin,Yoshiko Takeuchi,Kader Thiam,Robert D. Schreiber,Edward H. van der Horst

Nature Communicationsno. 1 (2024)

引用0浏览0WOSNATURE引用

Conditionally Active CD28xVISTA Bispecific Antibodies Induce Myeloid-Driven Tumor-Specific T-cell Co-Stimulation for Improved Cancer Immunotherapy

Thomas Thisted, Zhi-Gang Jiang,Zuzana Biesova, Adejumoke Onumajuru,Yuliya Kleschenko, Kanam Malhotra, Vikas Saxena,Arnab Mukherjee, F. Donelson Smith, Edward H. van der Horst

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Myeloid and Dendritic Cells Enhance Therapeutics-Induced Cytokine Release Syndrome Features in Humanized BRGSF-HIS Preclinical Model

Gaelle H. Martin,Alexis Gonon,Perrine Martin-Jeantet,Florence Renart-Depontieu,Zuzana Biesova,Anokhi Cifuentes,Arnab Mukherjee,Thomas Thisted,Astrid Doerner,Dean O. Campbell,Ludovic Bourre,Edward H. van der Horst,Amelie Rezza,Kader Thiam

FRONTIERS IN IMMUNOLOGY (2024)

引用0浏览0WOS引用

Abstract 5294: Conditionally active CD28xVISTA bispecific antibodies induce myeloid-driven tumor-specific T-cell co-stimulation for improved cancer immunotherapy

Thomas Thisted,Zhi-Gang Jiang,Zuzana Biesova, Adejumoke Onumajuru,Yuliya Kleschenko,Kanam Malhotra, Vikas Saxena,Arnab Mukherjee,F. Donelson Smith,Edward H. van der Horst

Cancer Researchno. 6_Supplement (2024): 5294-5294

引用0浏览0引用

485 Functional characterization of the inhibitory activity and identification of novel T-cell receptors for the tumor-associated macrophage receptor VSIG4

Tim Eitas,Edward van der Horst,Faith Finley,Thomas Thisted,Kanam Malhotra,Arnab Mukherjee,Zuzana Biesova,Anokhi Cifuentes, Sandra Marder, Paul Helbling,Robert Pierce

Regular and Young Investigator Award Abstracts (2022): A506-A506

引用0浏览0引用

Sns-101, a highly ph-selective vista:psgl-1 inhibitory antibody, potentiates anti-pd-1 sensitivity, expands memory t-cells and enhances tumor infiltration of cd8 t-cells

Thomas Thisted, Tim Eitas,Kanam Malhotra,Yuliya Kleschenko,Faith Finley,Zhi-Gang Jiang,Arnab Mukherjee,Zuzana Biesova,Anokhi Cifuentes,Robert Pierce,Edward van der Horst

Regular and Young Investigator Award Abstracts (2022): A895-A895

引用0浏览0引用

SNS-101, a Highly Selective Monoclonal Antibody Against the Active Form of VISTA, Demonstrates Significantly Reduced Cytokine Release

Edward Van der Horst,Zhi-Gang Jiang,Kanam Malhotra,Arnab Mukherjee,Zuzana Biesova,Anokhi Cifuentes,Thomas Thisted,Robert Hamilton Pierce,Gaelle Martin,Kader Thiam

Journal of clinical oncologyno. 16_suppl (2022): e14504-e14504

引用0浏览0引用

228 Antagonistic Ph-Selective VISTA Antibody SNS-101 Potentiates Anti-Pd-1/pd-l1-induced Anti-Tumor Immunity

Thomas Thisted,Arnab Mukherjee,Kanam Malhotra,Zuzana Biesova,Yuliya Kleschenko,Zhi-Gang Jiang,Anokhi Cifuentes,Nadthakarn Boland,Nels Nielson,Edward van der Horst

Journal for ImmunoTherapy of Cancer（2021）

引用3浏览0引用

Optimization of a Nicotine Degrading Enzyme for Potential Use in Treatment of Nicotine Addiction

Thomas Thisted,Zuzana Biesova, Celine Walmacq,Everett Stone, Max Rodnick-Smith,Shaheda S Ahmed,Stephen K Horrigan,Bo Van Engelen, Charles Reed,Matthew W Kalnik

BMC biotechnologyno. 1 (2019): 56-56

引用11浏览0WOS引用

The Nicotine-Degrading Enzyme NicA2 Reduces Nicotine Levels in Blood, Nicotine Distribution to Brain, and Nicotine Discrimination and Reinforcement in Rats

Paul R. Pentel,Michael D. Raleigh,Mark G. LeSage,Thomas Thisted,Stephen Horrigan,Zuzana Biesova,Matthew W. Kalnik

BMC biotechnology（2018）

引用10浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn